Aberrant methylation of miR-34b is associated with long-term shiftwork: a potential mechanism for increased breast cancer susceptibility

Cancer Causes and Control

Volumn 26, Issue 2, 2015, Pages 171-178

  Liu, Ran ^a,b   Jacobs, Daniel I ^a   Hansen, Johnni ^c   Fu, Alan ^a   Stevens, Richard G ^d   Zhu, Yong ^a  

^a YALE UNIVERSITY   (United States)

^b SOUTHEAST UNIVERSITY   (China)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Breast cancer; Methylation; MicroRNAs; MiR 34b; Shiftwork

Indexed keywords

FOLIC ACID; INTERFERON; MICRORNA; MICRORNA 34B; UNCLASSIFIED DRUG; MIRN34 MICRORNA, HUMAN;

ADULT; ANTIPROLIFERATIVE GENE NETWORK; APOPTOTIC GENE NETWORK; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CPG ISLAND; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN GENOME; IMMUNE RESPONSE; MCF 7 CELL LINE; MIR 34B GENE; MOLECULAR GENETICS; OCCUPATIONAL CANCER; OCCUPATIONAL CARCINOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RNA METHYLATION; RNA TRANSCRIPTION; SHIFT WORKER; VITAMIN INTAKE; WORK SCHEDULE; APOPTOSIS; BREAST TUMOR; CHEMISTRY; DISEASE PREDISPOSITION; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; GENE REGULATORY NETWORK; GENETICS; GENOME-WIDE ASSOCIATION STUDY; LIGHT; MIDDLE AGED; OCCUPATIONAL DISEASE; QUESTIONNAIRE; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; COHORT STUDIES; DISEASE SUSCEPTIBILITY; DNA METHYLATION; EPIGENOMICS; FEMALE; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIGHT; MICRORNAS; MIDDLE AGED; OCCUPATIONAL DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; WORK SCHEDULE TOLERANCE;

EID: 84922076754     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0494-z     Document Type: Article

References (48)

1. Akerstedt T (2003) Shift work and disturbed sleep/wakefulness. Occup Med (Lond) 53:89–94
2. Knutsson A (2003) Health disorders of shift workers. Occup Med (Lond) 53:103–108
3. Thomas C, Power C (2010) Shift work and risk factors for cardiovascular disease: a study at age 45 years in the 1958 British birth cohort. Eur J Epidemiol 25:305–314
4. van Mark A, Weiler SW, Schroder M et al (2010) The impact of shift work induced chronic circadian disruption on IL-6 and TNF-alpha immune responses. J Occup Med Toxicol 5:18
5. Costa G, Haus E, Stevens R (2010) Shift work and cancer—considerations on rationale, mechanisms, and epidemiology. Scand J Work Environ Health 36:163–179
6. Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93:1557–1562
7. Hansen J (2006) Risk of breast cancer after night- and shift work: current evidence and ongoing studies in Denmark. Cancer Causes Control 17:531–537
8. Hansen J, Stevens RG (2012) Case–control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer 48:1722–1729
9. Reed VA (2011) Shift work, light at night, and the risk of breast cancer. AAOHN J. 59: 37–45; quiz 6
10. Straif K, Baan R, Grosse Y et al (2007) Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 8:1065–1066
11. Erren TC (2010) Shift work, cancer and “white-box” epidemiology: association and causation. Epidemiol Perspect Innov 7:11
12. Shi F, Chen X, Fu A et al (2013) Aberrant DNA methylation of miR-219 promoter in long-term night shiftworkers. Environ Mol Mutagen 54:406–413
13. Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355
14. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68:2094–2105
15. Lopez-Serra P, Esteller M (2012) DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 31:1609–1622
16. Lujambio A, Calin GA, Villanueva A et al (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105:13556–13561
17. Pigazzi M, Manara E, Baron E, Basso G (2009) miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. Cancer Res 69:2471–2478
18. Leucci E, Cocco M, Onnis A et al (2008) MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol 216:440–450
19. He L, He X, Lim LP et al (2007) A microRNA component of the p53 tumour suppressor network. Nature 447:1130–1134
20. He X, He L, Hannon GJ (2007) The guardian’s little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 67:11099–11101
21. Shi F, Chen X, Fu A et al (2013) Aberrant DNA methylation of miR-219 promoter in long-term night shiftworkers. Environ Mol Mutagen 54:406–413
22. Tjønneland A, Olsen A, Boll K et al (2007) Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35:432–441
23. Zhu Y, Stevens RG, Hoffman AE et al (2011) Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysis. Chronobiol Int 28:852–861
24. Jacobs DI, Hansen J, Fu A et al (2013) Methylation alterations at imprinted genes detected among long-term shiftworkers. Environ Mol Mutagen 54:141–146
25. Chudin E, Kruglyak S, Baker SC, Oeser S, Barker D, McDaniel TK (2006) A model of technical variation of microarray signals. J Comput Biol 13:996–1003
26. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408
27. Calvano SE, Xiao W, Richards DR et al (2005) A network-based analysis of systemic inflammation in humans. Nature 437:1032–1037
28. Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375–386
29. Kirchhoff S, Schaper F, Hauser H (1993) Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes. Nucleic Acids Res 21:2881–2889
30. Ernst J, Kellis M (2010) Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol 28:817–825
31. Hermeking H (2007) p53 enters the microRNA world. Cancer Cell 12:414–418
32. Bommer GT, Gerin I, Feng Y et al (2007) p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17:1298–1307
33. He L, He X, Lim LP et al (2007) A microRNA component of the p53 tumour suppressor network. Nature 447:1130–1134
34. Raver-Shapira N, Marciano E, Meiri E et al (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26:731–743
35. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY (2007) MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67:8433–8438
36. He L, He X, Lowe SW, Hannon GJ (2007) microRNAs join the p53 network–another piece in the tumour-suppression puzzle. Nat Rev Cancer 7:819–822
37. Boominathan L (2010) The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network. Cancer Metastasis Rev 29:613–639
38. Takaoka A, Hayakawa S, Yanai H et al (2003) Integration of interferon-[alpha]/[beta] signalling to p53 responses in tumour suppression and antiviral defence. Nature 424:516–523
39. Ossina NK, Cannas A, Powers VC et al (1997) Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 272:16351–16357
40. Chen X, Hu H, Guan X et al (2012) CpG island methylation status of miRNAs in esophageal squamous cell carcinoma. Int J Cancer 130:1607–1613
41. Hermeking H (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ 17:193–199
42. Kalimutho M, Di Cecilia S, Del Vecchio Blanco G et al (2011) Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer. Br J Cancer 104:1770–1778
43. Pigazzi M, Manara E, Baron E, Basso G (2009) miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. Cancer Res 69:2471–2478
44. Toyota M, Suzuki H, Sasaki Y et al (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68:4123–4132
45. Wang Z, Chen Z, Gao Y et al (2011) DNA hypermethylation of microRNA-34b/c has prognostic value for stage non-small cell lung cancer. Cancer Biol Ther 11:490–496
46. Wiggins JF, Ruffino L, Kelnar K et al (2010) Development of a lung cancer therapeutic based on the tumor suppressor microrna-34. Cancer Res 70:5923–5930
47. Kasinski AL, Slack FJ (2012) miRNA-34 prevents cancer initiation and progression in a therapeutically resistant k-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Res 72:5576–5587
48. Widschwendter M, Apostolidou S, Raum E et al (2008) Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS ONE 3:e2656